|
GB8724885D0
(en)
|
1987-10-23 |
1987-11-25 |
Binns M M |
Fowlpox virus promotors
|
|
US5674722A
(en)
|
1987-12-11 |
1997-10-07 |
Somatix Therapy Corporation |
Genetic modification of endothelial cells
|
|
US5420032A
(en)
|
1991-12-23 |
1995-05-30 |
Universitge Laval |
Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
|
|
US5792632A
(en)
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
|
AU4645697A
(en)
|
1996-09-11 |
1998-04-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Aav4 vector and uses thereof
|
|
WO1998041641A1
(en)
|
1997-03-20 |
1998-09-24 |
The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
|
|
US6361996B1
(en)
|
1997-05-07 |
2002-03-26 |
University Of Utah Research Foundation |
Neuroepithelial stem cells and glial-restricted intermediate precursors
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US8263402B1
(en)
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US6503717B2
(en)
|
1999-12-06 |
2003-01-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
AU2001250774B2
(en)
|
2000-02-08 |
2005-01-27 |
Sangamo Biosciences, Inc. |
Cells expressing zinc finger proteins for drug discovery
|
|
US8273570B2
(en)
|
2000-05-16 |
2012-09-25 |
Riken |
Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
|
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
WO2002092134A1
(en)
|
2001-05-14 |
2002-11-21 |
Cell Genesys, Inc. |
Lentiviral vectors encoding clotting factors for gene therapy
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
US20040224385A1
(en)
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
|
US7355012B2
(en)
|
2001-09-26 |
2008-04-08 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
|
|
CA2462628C
(en)
|
2001-10-02 |
2019-08-20 |
Institut Clayton De La Recherche |
Restricted expression lentiviral vectors
|
|
CN103589692B
(zh)
|
2001-11-13 |
2018-07-24 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
EP1463805B1
(en)
|
2001-12-17 |
2014-10-22 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
SE0200198D0
(sv)
|
2002-01-23 |
2002-01-23 |
Astrazeneca Ab |
New use
|
|
US20030223972A1
(en)
|
2002-02-15 |
2003-12-04 |
Goldman Steven A. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US20040102402A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of tissue factor expression
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
ES2348868T3
(es)
|
2002-12-13 |
2010-12-16 |
Genetix Pharmaceuticals Inc. |
Vectores retrovirales terapeuticos para terapia genica.
|
|
WO2004081172A2
(en)
|
2003-03-12 |
2004-09-23 |
Reliance Life Sciences Pvt. Ltd. |
Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
DE602004027291D1
(de)
|
2003-11-25 |
2010-07-01 |
Us Gov Health & Human Serv |
Mutierte anti-cd22-antikörper und immunkonjugate
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7452718B2
(en)
|
2004-03-26 |
2008-11-18 |
Geron Corporation |
Direct differentiation method for making cardiomyocytes from human embryonic stem cells
|
|
ATE418346T1
(de)
|
2004-04-08 |
2009-01-15 |
Sangamo Biosciences Inc |
Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
|
|
US7253273B2
(en)
|
2004-04-08 |
2007-08-07 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
|
DE23193606T1
(de)
|
2005-04-07 |
2024-02-15 |
The Trustees Of The University Of Pennsylvania |
Verfahren zur erhöhung der funktion eines aav-vektors
|
|
KR20130099253A
(ko)
|
2005-06-22 |
2013-09-05 |
제론 코포레이션 |
영장류 다능성 줄기 세포의 심근세포 계통 세포로의 분화
|
|
DK3246403T3
(da)
|
2005-10-18 |
2020-10-26 |
Prec Biosciences |
Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
|
|
EP2132322A4
(en)
|
2007-03-02 |
2013-02-20 |
Richmond Chemical Corp |
METHOD FOR INCREASING YIELD AND IMPROVING PURIFICATION OF PRODUCTS FROM REACTIONS WITH TRANSAMINASE
|
|
ES2708856T3
(es)
|
2007-08-03 |
2019-04-11 |
Pasteur Institut |
Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales
|
|
EP2028268A1
(en)
|
2007-08-20 |
2009-02-25 |
Université Libre De Bruxelles |
Generation of neuronal cells from pluripotent stem cells
|
|
WO2009057111A2
(en)
|
2007-10-29 |
2009-05-07 |
Hadasit Medical Research Services & Development Limited |
Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
|
|
US8227247B2
(en)
|
2007-12-20 |
2012-07-24 |
Wisconsin Alumni Research Foundation |
Method of generating myelinating oligodendrocytes
|
|
US8728812B2
(en)
|
2008-04-22 |
2014-05-20 |
President And Fellows Of Harvard College |
Compositions and methods for promoting the generation of PDX1+ pancreatic cells
|
|
US9709553B2
(en)
|
2008-05-08 |
2017-07-18 |
University Of Rochester |
Treating myelin diseases with optimized cell preparations
|
|
WO2010008486A2
(en)
|
2008-06-24 |
2010-01-21 |
Parkinsons Institute |
Pluripotent cell lines and methods of use thereof
|
|
US9683215B2
(en)
|
2008-08-22 |
2017-06-20 |
President And Fellows Of Harvard College |
Methods of reprogramming cells
|
|
CN102325878A
(zh)
|
2008-12-23 |
2012-01-18 |
斯特姆塞尔思加利福尼亚有限公司 |
少突胶质前体细胞的靶向细胞群及制备与使用方法
|
|
US8507274B2
(en)
|
2009-02-06 |
2013-08-13 |
President And Fellows Of Harvard College |
Compositions and methods for promoting the generation of definitive endoderm
|
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
|
US9057053B2
(en)
|
2010-01-19 |
2015-06-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Direct conversion of cells to cells of other lineages
|
|
WO2011130675A2
(en)
|
2010-04-16 |
2011-10-20 |
The Mclean Hospital Corporation |
Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof
|
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
US9193951B2
(en)
|
2010-10-26 |
2015-11-24 |
Case Western Reserve University |
Differentiation method for production of glial cell populations
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
CA2829804A1
(en)
|
2011-03-29 |
2012-10-04 |
Geron Corporation |
Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
|
|
CA2831609C
(en)
|
2011-03-30 |
2019-06-11 |
Cellular Dynamics International, Inc. |
Priming of pluripotent stem cells for neural differentiation
|
|
US20140115726A1
(en)
|
2011-04-05 |
2014-04-24 |
Cellectis |
New tale-protein scaffolds and uses thereof
|
|
KR101966208B1
(ko)
|
2011-07-21 |
2019-04-09 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
환자로부터 유도 만능 줄기 세포들로부터의 심근 세포 및 그 사용 방법
|
|
KR20140060541A
(ko)
|
2011-09-16 |
2014-05-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암을 치료하기 위한 rna 조작된 t 세포
|
|
US8951798B2
(en)
|
2011-10-13 |
2015-02-10 |
Wisconsin Alumni Research Foundation |
Generation of cardiomyocytes from human pluripotent stem cells
|
|
US20140359799A1
(en)
|
2011-12-23 |
2014-12-04 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
US9850463B2
(en)
|
2012-02-01 |
2017-12-26 |
The Regents Of The University Of California |
Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
|
|
CA2865011C
(en)
|
2012-02-29 |
2021-06-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
AU2013246443B2
(en)
|
2012-04-11 |
2017-04-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric antigen receptors targeting B-cell maturation antigen
|
|
WO2013184809A1
(en)
|
2012-06-05 |
2013-12-12 |
The Regents Of The University Of California |
Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
|
|
GB201212902D0
(en)
|
2012-07-20 |
2012-09-05 |
Univ Singapore |
Combinatoric encoding methods for microarrays
|
|
EP2914628A1
(en)
|
2012-11-01 |
2015-09-09 |
Max-Delbrück-Centrum für Molekulare Medizin |
An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
|
|
EP3766962B1
(en)
|
2013-02-06 |
2025-10-22 |
University of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
JP6756610B2
(ja)
|
2013-04-26 |
2020-09-16 |
メモリアル スローン ケタリング キャンサー センター |
多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
|
|
EP3243831A1
(en)
|
2014-02-27 |
2017-11-15 |
Ucl Business Plc |
Variants of the proliferation-inducing ligand (april)
|
|
BR112016024546A2
(pt)
|
2014-04-30 |
2018-01-23 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
anticorpo ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo isolado, conjugado de anticorpo-fármaco, molécula de ácido nucleico, célula hospedeira, e, composição farmacêutica
|
|
JP6873705B2
(ja)
|
2014-05-22 |
2021-05-19 |
ニューヨーク ステム セル ファウンデーション インコーポレイテッド |
多能性幹細胞由来の機能性オリゴデンドロサイト、ならびにその作製方法及び使用方法
|
|
WO2015182765A1
(ja)
|
2014-05-30 |
2015-12-03 |
国立大学法人京都大学 |
低分子化合物を用いた多能性幹細胞の心筋分化誘導法
|
|
AU2015292744C1
(en)
|
2014-07-21 |
2021-01-21 |
Novartis Ag |
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
|
|
EP3172231B1
(en)
|
2014-07-24 |
2021-05-05 |
Bluebird Bio, Inc. |
Bcma chimeric antigen receptors
|
|
ES2688035T3
(es)
|
2014-08-29 |
2018-10-30 |
Gemoab Monoclonals Gmbh |
Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
|
|
US9765299B2
(en)
|
2014-09-10 |
2017-09-19 |
Wisconsin Alumni Research Foundation |
Chemically defined albumin-free conditions for cardiomyocyte differentiation of human pluripotent stem cells
|
|
WO2016126608A1
(en)
|
2015-02-02 |
2016-08-11 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
|
BR112017020750A2
(en)
|
2015-03-27 |
2018-06-26 |
President And Fellows Of Harvard College |
modified t-cells and methods of producing and using them
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
EP3294342A4
(en)
|
2015-05-08 |
2018-11-07 |
President and Fellows of Harvard College |
Universal donor stem cells and related methods
|
|
CA2995634A1
(en)
|
2015-08-15 |
2017-02-23 |
Asterias Biotherapeutics, Inc. |
Stem cell-derived oligodendrocyte progenitor cells for the treatment of white matter stroke
|
|
US20180291080A1
(en)
|
2015-09-28 |
2018-10-11 |
Trustees Of Dartmouth College |
Chimeric antigen receptor, regulatory cells and methods of use
|
|
EP3858388B1
(en)
|
2015-09-28 |
2024-07-03 |
Regents of the University of Minnesota |
Chimeric antigen receptor (car) t cells as therapeutic interventions for gvhd
|
|
CA3016575A1
(en)
|
2016-03-03 |
2017-09-08 |
New York Stem Cell Foundation, Inc. |
Microglia derived from pluripotent stem cells and methods of making and using the same
|
|
WO2017172976A1
(en)
|
2016-03-29 |
2017-10-05 |
The Regents Of The University Of California |
Methods for promoting oligodendrocyte regeneration and remyelination
|
|
CN118652336A
(zh)
|
2016-06-08 |
2024-09-17 |
普瑞赛格恩公司 |
Cd33特异性嵌合抗原受体
|
|
KR101988912B1
(ko)
|
2016-07-08 |
2019-06-13 |
서울대학교산학협력단 |
패턴을 이용한 조골세포 분화 촉진용 배양지지체
|
|
WO2018093681A1
(en)
|
2016-11-15 |
2018-05-24 |
Neuralstem, Inc. |
Multipotent neural stem cells that express platelet derived growth factor (pdgf) receptor and methods of use thereof
|
|
KR20240095477A
(ko)
|
2017-01-13 |
2024-06-25 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
면역조작된 만능 세포
|
|
AU2018269194B2
(en)
|
2017-05-15 |
2025-05-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bicistronic chimeric antigen receptors and their uses
|
|
WO2019005886A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS
|
|
CN111328290A
(zh)
|
2017-06-26 |
2020-06-23 |
博德研究所 |
用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法
|
|
WO2019126762A2
(en)
|
2017-12-22 |
2019-06-27 |
The Broad Institute, Inc. |
Cas12a systems, methods, and compositions for targeted rna base editing
|
|
US20230193242A1
(en)
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
|
EP3728576A4
(en)
|
2017-12-22 |
2021-11-24 |
The Broad Institute, Inc. |
CAS12B SYSTEMS, METHODS AND COMPOSITIONS FOR SPECIFIC EDITING OF RNA BASES
|
|
CA3100382A1
(en)
|
2018-05-16 |
2019-11-21 |
Washington University |
Methods and compositions for generating cells of endodermal lineage and beta cells and uses thereof
|
|
EP3824075A4
(en)
|
2018-07-17 |
2022-04-20 |
The Regents of The University of California |
CHIMERA ANTIGEN RECEPTOR T-CELLS DERIVED FROM IMMUNOMANIPULATED PLURIPOTENTS STEM CELLS
|
|
AU2019305585A1
(en)
|
2018-07-17 |
2021-01-28 |
The Regents Of The University Of California |
Cells differentiated from immunoengineered pluripotent cells
|
|
EP3850088A4
(en)
|
2018-09-07 |
2023-07-19 |
Beam Therapeutics, Inc. |
Compositions and methods for improving base editing
|
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
|
WO2020181193A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
JP7853210B2
(ja)
|
2020-01-13 |
2026-04-28 |
サナ バイオテクノロジー，インコーポレイテッド |
血液型抗原の修飾
|
|
US20230235309A1
(en)
|
2020-02-05 |
2023-07-27 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
AU2021325941A1
(en)
*
|
2020-08-13 |
2023-03-09 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
CA3193099A1
(en)
|
2020-09-24 |
2022-03-31 |
David R. Liu |
Prime editing guide rnas, compositions thereof, and methods of using the same
|
|
US11965022B2
(en)
*
|
2020-12-31 |
2024-04-23 |
Sana Biotechnology, Inc. |
Methods and compositions for modulating CAR-T activity
|